Global Oncology Injection Drug Market Research Report 2024, Forecast to 2032
Report Overview
An oncology injection drug refers to a medication administered by injection for the treatment of cancer. These drugs can be chemotherapy agents, targeted therapies, immunotherapies, or supportive medications.
The global Oncology Injection Drug market size was estimated at USD 122 million in 2023 and is projected to reach USD 202.64 million by 2032, exhibiting a CAGR of 5.80% during the forecast period.
North America Oncology Injection Drug market size was estimated at USD 35.03 million in 2023, at a CAGR of 4.97% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Oncology Injection Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Injection Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Injection Drug market in any manner.
Global Oncology Injection Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience
Market Segmentation (by Type)
Organs
Central Nervous System
Circulatory/Musculoskeletal System
Other
Market Segmentation (by Application)
Lymphoma
Myeloma
Prostate Cancer
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Injection Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncology Injection Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
An oncology injection drug refers to a medication administered by injection for the treatment of cancer. These drugs can be chemotherapy agents, targeted therapies, immunotherapies, or supportive medications.
The global Oncology Injection Drug market size was estimated at USD 122 million in 2023 and is projected to reach USD 202.64 million by 2032, exhibiting a CAGR of 5.80% during the forecast period.
North America Oncology Injection Drug market size was estimated at USD 35.03 million in 2023, at a CAGR of 4.97% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Oncology Injection Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Injection Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Injection Drug market in any manner.
Global Oncology Injection Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience
Market Segmentation (by Type)
Organs
Central Nervous System
Circulatory/Musculoskeletal System
Other
Market Segmentation (by Application)
Lymphoma
Myeloma
Prostate Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Oncology Injection Drug Market
- Overview of the regional outlook of the Oncology Injection Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Injection Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncology Injection Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncology Injection Drug
1.2 Key Market Segments
1.2.1 Oncology Injection Drug Segment by Type
1.2.2 Oncology Injection Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY INJECTION DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Injection Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Oncology Injection Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY INJECTION DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncology Injection Drug Sales by Manufacturers (2019-2024)
3.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Injection Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Injection Drug Sales Sites, Area Served, Product Type
3.6 Oncology Injection Drug Market Competitive Situation and Trends
3.6.1 Oncology Injection Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Injection Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY INJECTION DRUG INDUSTRY CHAIN ANALYSIS
4.1 Oncology Injection Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY INJECTION DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLOGY INJECTION DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Injection Drug Sales Market Share by Type (2019-2024)
6.3 Global Oncology Injection Drug Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Injection Drug Price by Type (2019-2024)
7 ONCOLOGY INJECTION DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Injection Drug Market Sales by Application (2019-2024)
7.3 Global Oncology Injection Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Injection Drug Sales Growth Rate by Application (2019-2024)
8 ONCOLOGY INJECTION DRUG MARKET CONSUMPTION BY REGION
8.1 Global Oncology Injection Drug Sales by Region
8.1.1 Global Oncology Injection Drug Sales by Region
8.1.2 Global Oncology Injection Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Injection Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Injection Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Injection Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Injection Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Injection Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ONCOLOGY INJECTION DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Oncology Injection Drug by Region (2019-2024)
9.2 Global Oncology Injection Drug Revenue Market Share by Region (2019-2024)
9.3 Global Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Oncology Injection Drug Production
9.4.1 North America Oncology Injection Drug Production Growth Rate (2019-2024)
9.4.2 North America Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Oncology Injection Drug Production
9.5.1 Europe Oncology Injection Drug Production Growth Rate (2019-2024)
9.5.2 Europe Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Oncology Injection Drug Production (2019-2024)
9.6.1 Japan Oncology Injection Drug Production Growth Rate (2019-2024)
9.6.2 Japan Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Oncology Injection Drug Production (2019-2024)
9.7.1 China Oncology Injection Drug Production Growth Rate (2019-2024)
9.7.2 China Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Taj Oncology
10.1.1 Taj Oncology Oncology Injection Drug Basic Information
10.1.2 Taj Oncology Oncology Injection Drug Product Overview
10.1.3 Taj Oncology Oncology Injection Drug Product Market Performance
10.1.4 Taj Oncology Business Overview
10.1.5 Taj Oncology Oncology Injection Drug SWOT Analysis
10.1.6 Taj Oncology Recent Developments
10.2 S.G. Biopharm
10.2.1 S.G. Biopharm Oncology Injection Drug Basic Information
10.2.2 S.G. Biopharm Oncology Injection Drug Product Overview
10.2.3 S.G. Biopharm Oncology Injection Drug Product Market Performance
10.2.4 S.G. Biopharm Business Overview
10.2.5 S.G. Biopharm Oncology Injection Drug SWOT Analysis
10.2.6 S.G. Biopharm Recent Developments
10.3 AdvaCare
10.3.1 AdvaCare Oncology Injection Drug Basic Information
10.3.2 AdvaCare Oncology Injection Drug Product Overview
10.3.3 AdvaCare Oncology Injection Drug Product Market Performance
10.3.4 AdvaCare Oncology Injection Drug SWOT Analysis
10.3.5 AdvaCare Business Overview
10.3.6 AdvaCare Recent Developments
10.4 Merrimack
10.4.1 Merrimack Oncology Injection Drug Basic Information
10.4.2 Merrimack Oncology Injection Drug Product Overview
10.4.3 Merrimack Oncology Injection Drug Product Market Performance
10.4.4 Merrimack Business Overview
10.4.5 Merrimack Recent Developments
10.5 Celgene
10.5.1 Celgene Oncology Injection Drug Basic Information
10.5.2 Celgene Oncology Injection Drug Product Overview
10.5.3 Celgene Oncology Injection Drug Product Market Performance
10.5.4 Celgene Business Overview
10.5.5 Celgene Recent Developments
10.6 Allos Therapeutics
10.6.1 Allos Therapeutics Oncology Injection Drug Basic Information
10.6.2 Allos Therapeutics Oncology Injection Drug Product Overview
10.6.3 Allos Therapeutics Oncology Injection Drug Product Market Performance
10.6.4 Allos Therapeutics Business Overview
10.6.5 Allos Therapeutics Recent Developments
10.7 Ferring Pharmaceuticals
10.7.1 Ferring Pharmaceuticals Oncology Injection Drug Basic Information
10.7.2 Ferring Pharmaceuticals Oncology Injection Drug Product Overview
10.7.3 Ferring Pharmaceuticals Oncology Injection Drug Product Market Performance
10.7.4 Ferring Pharmaceuticals Business Overview
10.7.5 Ferring Pharmaceuticals Recent Developments
10.8 Genzyme
10.8.1 Genzyme Oncology Injection Drug Basic Information
10.8.2 Genzyme Oncology Injection Drug Product Overview
10.8.3 Genzyme Oncology Injection Drug Product Market Performance
10.8.4 Genzyme Business Overview
10.8.5 Genzyme Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Oncology Injection Drug Basic Information
10.9.2 Eli Lilly Oncology Injection Drug Product Overview
10.9.3 Eli Lilly Oncology Injection Drug Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 Praecis Pharmaceuticals
10.10.1 Praecis Pharmaceuticals Oncology Injection Drug Basic Information
10.10.2 Praecis Pharmaceuticals Oncology Injection Drug Product Overview
10.10.3 Praecis Pharmaceuticals Oncology Injection Drug Product Market Performance
10.10.4 Praecis Pharmaceuticals Business Overview
10.10.5 Praecis Pharmaceuticals Recent Developments
10.11 Millennium Pharmaceuticals
10.11.1 Millennium Pharmaceuticals Oncology Injection Drug Basic Information
10.11.2 Millennium Pharmaceuticals Oncology Injection Drug Product Overview
10.11.3 Millennium Pharmaceuticals Oncology Injection Drug Product Market Performance
10.11.4 Millennium Pharmaceuticals Business Overview
10.11.5 Millennium Pharmaceuticals Recent Developments
10.12 Debiopharm
10.12.1 Debiopharm Oncology Injection Drug Basic Information
10.12.2 Debiopharm Oncology Injection Drug Product Overview
10.12.3 Debiopharm Oncology Injection Drug Product Market Performance
10.12.4 Debiopharm Business Overview
10.12.5 Debiopharm Recent Developments
10.13 Alza
10.13.1 Alza Oncology Injection Drug Basic Information
10.13.2 Alza Oncology Injection Drug Product Overview
10.13.3 Alza Oncology Injection Drug Product Market Performance
10.13.4 Alza Business Overview
10.13.5 Alza Recent Developments
10.14 CordenPharma
10.14.1 CordenPharma Oncology Injection Drug Basic Information
10.14.2 CordenPharma Oncology Injection Drug Product Overview
10.14.3 CordenPharma Oncology Injection Drug Product Market Performance
10.14.4 CordenPharma Business Overview
10.14.5 CordenPharma Recent Developments
10.15 Pharmascience
10.15.1 Pharmascience Oncology Injection Drug Basic Information
10.15.2 Pharmascience Oncology Injection Drug Product Overview
10.15.3 Pharmascience Oncology Injection Drug Product Market Performance
10.15.4 Pharmascience Business Overview
10.15.5 Pharmascience Recent Developments
11 ONCOLOGY INJECTION DRUG MARKET FORECAST BY REGION
11.1 Global Oncology Injection Drug Market Size Forecast
11.2 Global Oncology Injection Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncology Injection Drug Market Size Forecast by Country
11.2.3 Asia Pacific Oncology Injection Drug Market Size Forecast by Region
11.2.4 South America Oncology Injection Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Oncology Injection Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Oncology Injection Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Oncology Injection Drug by Type (2025-2032)
12.1.2 Global Oncology Injection Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Oncology Injection Drug by Type (2025-2032)
12.2 Global Oncology Injection Drug Market Forecast by Application (2025-2032)
12.2.1 Global Oncology Injection Drug Sales (K MT) Forecast by Application
12.2.2 Global Oncology Injection Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncology Injection Drug
1.2 Key Market Segments
1.2.1 Oncology Injection Drug Segment by Type
1.2.2 Oncology Injection Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY INJECTION DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Injection Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Oncology Injection Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY INJECTION DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncology Injection Drug Sales by Manufacturers (2019-2024)
3.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Injection Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Injection Drug Sales Sites, Area Served, Product Type
3.6 Oncology Injection Drug Market Competitive Situation and Trends
3.6.1 Oncology Injection Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Injection Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY INJECTION DRUG INDUSTRY CHAIN ANALYSIS
4.1 Oncology Injection Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY INJECTION DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLOGY INJECTION DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Injection Drug Sales Market Share by Type (2019-2024)
6.3 Global Oncology Injection Drug Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Injection Drug Price by Type (2019-2024)
7 ONCOLOGY INJECTION DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Injection Drug Market Sales by Application (2019-2024)
7.3 Global Oncology Injection Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Injection Drug Sales Growth Rate by Application (2019-2024)
8 ONCOLOGY INJECTION DRUG MARKET CONSUMPTION BY REGION
8.1 Global Oncology Injection Drug Sales by Region
8.1.1 Global Oncology Injection Drug Sales by Region
8.1.2 Global Oncology Injection Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Injection Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Injection Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Injection Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Injection Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Injection Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ONCOLOGY INJECTION DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Oncology Injection Drug by Region (2019-2024)
9.2 Global Oncology Injection Drug Revenue Market Share by Region (2019-2024)
9.3 Global Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Oncology Injection Drug Production
9.4.1 North America Oncology Injection Drug Production Growth Rate (2019-2024)
9.4.2 North America Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Oncology Injection Drug Production
9.5.1 Europe Oncology Injection Drug Production Growth Rate (2019-2024)
9.5.2 Europe Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Oncology Injection Drug Production (2019-2024)
9.6.1 Japan Oncology Injection Drug Production Growth Rate (2019-2024)
9.6.2 Japan Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Oncology Injection Drug Production (2019-2024)
9.7.1 China Oncology Injection Drug Production Growth Rate (2019-2024)
9.7.2 China Oncology Injection Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Taj Oncology
10.1.1 Taj Oncology Oncology Injection Drug Basic Information
10.1.2 Taj Oncology Oncology Injection Drug Product Overview
10.1.3 Taj Oncology Oncology Injection Drug Product Market Performance
10.1.4 Taj Oncology Business Overview
10.1.5 Taj Oncology Oncology Injection Drug SWOT Analysis
10.1.6 Taj Oncology Recent Developments
10.2 S.G. Biopharm
10.2.1 S.G. Biopharm Oncology Injection Drug Basic Information
10.2.2 S.G. Biopharm Oncology Injection Drug Product Overview
10.2.3 S.G. Biopharm Oncology Injection Drug Product Market Performance
10.2.4 S.G. Biopharm Business Overview
10.2.5 S.G. Biopharm Oncology Injection Drug SWOT Analysis
10.2.6 S.G. Biopharm Recent Developments
10.3 AdvaCare
10.3.1 AdvaCare Oncology Injection Drug Basic Information
10.3.2 AdvaCare Oncology Injection Drug Product Overview
10.3.3 AdvaCare Oncology Injection Drug Product Market Performance
10.3.4 AdvaCare Oncology Injection Drug SWOT Analysis
10.3.5 AdvaCare Business Overview
10.3.6 AdvaCare Recent Developments
10.4 Merrimack
10.4.1 Merrimack Oncology Injection Drug Basic Information
10.4.2 Merrimack Oncology Injection Drug Product Overview
10.4.3 Merrimack Oncology Injection Drug Product Market Performance
10.4.4 Merrimack Business Overview
10.4.5 Merrimack Recent Developments
10.5 Celgene
10.5.1 Celgene Oncology Injection Drug Basic Information
10.5.2 Celgene Oncology Injection Drug Product Overview
10.5.3 Celgene Oncology Injection Drug Product Market Performance
10.5.4 Celgene Business Overview
10.5.5 Celgene Recent Developments
10.6 Allos Therapeutics
10.6.1 Allos Therapeutics Oncology Injection Drug Basic Information
10.6.2 Allos Therapeutics Oncology Injection Drug Product Overview
10.6.3 Allos Therapeutics Oncology Injection Drug Product Market Performance
10.6.4 Allos Therapeutics Business Overview
10.6.5 Allos Therapeutics Recent Developments
10.7 Ferring Pharmaceuticals
10.7.1 Ferring Pharmaceuticals Oncology Injection Drug Basic Information
10.7.2 Ferring Pharmaceuticals Oncology Injection Drug Product Overview
10.7.3 Ferring Pharmaceuticals Oncology Injection Drug Product Market Performance
10.7.4 Ferring Pharmaceuticals Business Overview
10.7.5 Ferring Pharmaceuticals Recent Developments
10.8 Genzyme
10.8.1 Genzyme Oncology Injection Drug Basic Information
10.8.2 Genzyme Oncology Injection Drug Product Overview
10.8.3 Genzyme Oncology Injection Drug Product Market Performance
10.8.4 Genzyme Business Overview
10.8.5 Genzyme Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Oncology Injection Drug Basic Information
10.9.2 Eli Lilly Oncology Injection Drug Product Overview
10.9.3 Eli Lilly Oncology Injection Drug Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 Praecis Pharmaceuticals
10.10.1 Praecis Pharmaceuticals Oncology Injection Drug Basic Information
10.10.2 Praecis Pharmaceuticals Oncology Injection Drug Product Overview
10.10.3 Praecis Pharmaceuticals Oncology Injection Drug Product Market Performance
10.10.4 Praecis Pharmaceuticals Business Overview
10.10.5 Praecis Pharmaceuticals Recent Developments
10.11 Millennium Pharmaceuticals
10.11.1 Millennium Pharmaceuticals Oncology Injection Drug Basic Information
10.11.2 Millennium Pharmaceuticals Oncology Injection Drug Product Overview
10.11.3 Millennium Pharmaceuticals Oncology Injection Drug Product Market Performance
10.11.4 Millennium Pharmaceuticals Business Overview
10.11.5 Millennium Pharmaceuticals Recent Developments
10.12 Debiopharm
10.12.1 Debiopharm Oncology Injection Drug Basic Information
10.12.2 Debiopharm Oncology Injection Drug Product Overview
10.12.3 Debiopharm Oncology Injection Drug Product Market Performance
10.12.4 Debiopharm Business Overview
10.12.5 Debiopharm Recent Developments
10.13 Alza
10.13.1 Alza Oncology Injection Drug Basic Information
10.13.2 Alza Oncology Injection Drug Product Overview
10.13.3 Alza Oncology Injection Drug Product Market Performance
10.13.4 Alza Business Overview
10.13.5 Alza Recent Developments
10.14 CordenPharma
10.14.1 CordenPharma Oncology Injection Drug Basic Information
10.14.2 CordenPharma Oncology Injection Drug Product Overview
10.14.3 CordenPharma Oncology Injection Drug Product Market Performance
10.14.4 CordenPharma Business Overview
10.14.5 CordenPharma Recent Developments
10.15 Pharmascience
10.15.1 Pharmascience Oncology Injection Drug Basic Information
10.15.2 Pharmascience Oncology Injection Drug Product Overview
10.15.3 Pharmascience Oncology Injection Drug Product Market Performance
10.15.4 Pharmascience Business Overview
10.15.5 Pharmascience Recent Developments
11 ONCOLOGY INJECTION DRUG MARKET FORECAST BY REGION
11.1 Global Oncology Injection Drug Market Size Forecast
11.2 Global Oncology Injection Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncology Injection Drug Market Size Forecast by Country
11.2.3 Asia Pacific Oncology Injection Drug Market Size Forecast by Region
11.2.4 South America Oncology Injection Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Oncology Injection Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Oncology Injection Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Oncology Injection Drug by Type (2025-2032)
12.1.2 Global Oncology Injection Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Oncology Injection Drug by Type (2025-2032)
12.2 Global Oncology Injection Drug Market Forecast by Application (2025-2032)
12.2.1 Global Oncology Injection Drug Sales (K MT) Forecast by Application
12.2.2 Global Oncology Injection Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Injection Drug Market Size Comparison by Region (M USD)
Table 5. Global Oncology Injection Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Oncology Injection Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oncology Injection Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oncology Injection Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2022)
Table 10. Global Market Oncology Injection Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oncology Injection Drug Sales Sites and Area Served
Table 12. Manufacturers Oncology Injection Drug Product Type
Table 13. Global Oncology Injection Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncology Injection Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Injection Drug Market Challenges
Table 22. Global Oncology Injection Drug Sales by Type (K MT)
Table 23. Global Oncology Injection Drug Market Size by Type (M USD)
Table 24. Global Oncology Injection Drug Sales (K MT) by Type (2019-2024)
Table 25. Global Oncology Injection Drug Sales Market Share by Type (2019-2024)
Table 26. Global Oncology Injection Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Oncology Injection Drug Market Size Share by Type (2019-2024)
Table 28. Global Oncology Injection Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global Oncology Injection Drug Sales (K MT) by Application
Table 30. Global Oncology Injection Drug Market Size by Application
Table 31. Global Oncology Injection Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global Oncology Injection Drug Sales Market Share by Application (2019-2024)
Table 33. Global Oncology Injection Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Oncology Injection Drug Market Share by Application (2019-2024)
Table 35. Global Oncology Injection Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Oncology Injection Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global Oncology Injection Drug Sales Market Share by Region (2019-2024)
Table 38. North America Oncology Injection Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe Oncology Injection Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Oncology Injection Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America Oncology Injection Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Oncology Injection Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global Oncology Injection Drug Production (K MT) by Region (2019-2024)
Table 44. Global Oncology Injection Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Oncology Injection Drug Revenue Market Share by Region (2019-2024)
Table 46. Global Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Taj Oncology Oncology Injection Drug Basic Information
Table 52. Taj Oncology Oncology Injection Drug Product Overview
Table 53. Taj Oncology Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Taj Oncology Business Overview
Table 55. Taj Oncology Oncology Injection Drug SWOT Analysis
Table 56. Taj Oncology Recent Developments
Table 57. S.G. Biopharm Oncology Injection Drug Basic Information
Table 58. S.G. Biopharm Oncology Injection Drug Product Overview
Table 59. S.G. Biopharm Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. S.G. Biopharm Business Overview
Table 61. S.G. Biopharm Oncology Injection Drug SWOT Analysis
Table 62. S.G. Biopharm Recent Developments
Table 63. AdvaCare Oncology Injection Drug Basic Information
Table 64. AdvaCare Oncology Injection Drug Product Overview
Table 65. AdvaCare Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. AdvaCare Oncology Injection Drug SWOT Analysis
Table 67. AdvaCare Business Overview
Table 68. AdvaCare Recent Developments
Table 69. Merrimack Oncology Injection Drug Basic Information
Table 70. Merrimack Oncology Injection Drug Product Overview
Table 71. Merrimack Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Merrimack Business Overview
Table 73. Merrimack Recent Developments
Table 74. Celgene Oncology Injection Drug Basic Information
Table 75. Celgene Oncology Injection Drug Product Overview
Table 76. Celgene Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Celgene Business Overview
Table 78. Celgene Recent Developments
Table 79. Allos Therapeutics Oncology Injection Drug Basic Information
Table 80. Allos Therapeutics Oncology Injection Drug Product Overview
Table 81. Allos Therapeutics Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Allos Therapeutics Business Overview
Table 83. Allos Therapeutics Recent Developments
Table 84. Ferring Pharmaceuticals Oncology Injection Drug Basic Information
Table 85. Ferring Pharmaceuticals Oncology Injection Drug Product Overview
Table 86. Ferring Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Ferring Pharmaceuticals Business Overview
Table 88. Ferring Pharmaceuticals Recent Developments
Table 89. Genzyme Oncology Injection Drug Basic Information
Table 90. Genzyme Oncology Injection Drug Product Overview
Table 91. Genzyme Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Genzyme Business Overview
Table 93. Genzyme Recent Developments
Table 94. Eli Lilly Oncology Injection Drug Basic Information
Table 95. Eli Lilly Oncology Injection Drug Product Overview
Table 96. Eli Lilly Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Recent Developments
Table 99. Praecis Pharmaceuticals Oncology Injection Drug Basic Information
Table 100. Praecis Pharmaceuticals Oncology Injection Drug Product Overview
Table 101. Praecis Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Praecis Pharmaceuticals Business Overview
Table 103. Praecis Pharmaceuticals Recent Developments
Table 104. Millennium Pharmaceuticals Oncology Injection Drug Basic Information
Table 105. Millennium Pharmaceuticals Oncology Injection Drug Product Overview
Table 106. Millennium Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Millennium Pharmaceuticals Business Overview
Table 108. Millennium Pharmaceuticals Recent Developments
Table 109. Debiopharm Oncology Injection Drug Basic Information
Table 110. Debiopharm Oncology Injection Drug Product Overview
Table 111. Debiopharm Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Debiopharm Business Overview
Table 113. Debiopharm Recent Developments
Table 114. Alza Oncology Injection Drug Basic Information
Table 115. Alza Oncology Injection Drug Product Overview
Table 116. Alza Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Alza Business Overview
Table 118. Alza Recent Developments
Table 119. CordenPharma Oncology Injection Drug Basic Information
Table 120. CordenPharma Oncology Injection Drug Product Overview
Table 121. CordenPharma Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. CordenPharma Business Overview
Table 123. CordenPharma Recent Developments
Table 124. Pharmascience Oncology Injection Drug Basic Information
Table 125. Pharmascience Oncology Injection Drug Product Overview
Table 126. Pharmascience Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Pharmascience Business Overview
Table 128. Pharmascience Recent Developments
Table 129. Global Oncology Injection Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Oncology Injection Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Oncology Injection Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Oncology Injection Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Oncology Injection Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Oncology Injection Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Oncology Injection Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Oncology Injection Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Oncology Injection Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Oncology Injection Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Oncology Injection Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Oncology Injection Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Oncology Injection Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Oncology Injection Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Oncology Injection Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Oncology Injection Drug Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Oncology Injection Drug Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Injection Drug Market Size Comparison by Region (M USD)
Table 5. Global Oncology Injection Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Oncology Injection Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oncology Injection Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oncology Injection Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2022)
Table 10. Global Market Oncology Injection Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oncology Injection Drug Sales Sites and Area Served
Table 12. Manufacturers Oncology Injection Drug Product Type
Table 13. Global Oncology Injection Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncology Injection Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Injection Drug Market Challenges
Table 22. Global Oncology Injection Drug Sales by Type (K MT)
Table 23. Global Oncology Injection Drug Market Size by Type (M USD)
Table 24. Global Oncology Injection Drug Sales (K MT) by Type (2019-2024)
Table 25. Global Oncology Injection Drug Sales Market Share by Type (2019-2024)
Table 26. Global Oncology Injection Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Oncology Injection Drug Market Size Share by Type (2019-2024)
Table 28. Global Oncology Injection Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global Oncology Injection Drug Sales (K MT) by Application
Table 30. Global Oncology Injection Drug Market Size by Application
Table 31. Global Oncology Injection Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global Oncology Injection Drug Sales Market Share by Application (2019-2024)
Table 33. Global Oncology Injection Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Oncology Injection Drug Market Share by Application (2019-2024)
Table 35. Global Oncology Injection Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Oncology Injection Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global Oncology Injection Drug Sales Market Share by Region (2019-2024)
Table 38. North America Oncology Injection Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe Oncology Injection Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Oncology Injection Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America Oncology Injection Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Oncology Injection Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global Oncology Injection Drug Production (K MT) by Region (2019-2024)
Table 44. Global Oncology Injection Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Oncology Injection Drug Revenue Market Share by Region (2019-2024)
Table 46. Global Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Taj Oncology Oncology Injection Drug Basic Information
Table 52. Taj Oncology Oncology Injection Drug Product Overview
Table 53. Taj Oncology Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Taj Oncology Business Overview
Table 55. Taj Oncology Oncology Injection Drug SWOT Analysis
Table 56. Taj Oncology Recent Developments
Table 57. S.G. Biopharm Oncology Injection Drug Basic Information
Table 58. S.G. Biopharm Oncology Injection Drug Product Overview
Table 59. S.G. Biopharm Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. S.G. Biopharm Business Overview
Table 61. S.G. Biopharm Oncology Injection Drug SWOT Analysis
Table 62. S.G. Biopharm Recent Developments
Table 63. AdvaCare Oncology Injection Drug Basic Information
Table 64. AdvaCare Oncology Injection Drug Product Overview
Table 65. AdvaCare Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. AdvaCare Oncology Injection Drug SWOT Analysis
Table 67. AdvaCare Business Overview
Table 68. AdvaCare Recent Developments
Table 69. Merrimack Oncology Injection Drug Basic Information
Table 70. Merrimack Oncology Injection Drug Product Overview
Table 71. Merrimack Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Merrimack Business Overview
Table 73. Merrimack Recent Developments
Table 74. Celgene Oncology Injection Drug Basic Information
Table 75. Celgene Oncology Injection Drug Product Overview
Table 76. Celgene Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Celgene Business Overview
Table 78. Celgene Recent Developments
Table 79. Allos Therapeutics Oncology Injection Drug Basic Information
Table 80. Allos Therapeutics Oncology Injection Drug Product Overview
Table 81. Allos Therapeutics Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Allos Therapeutics Business Overview
Table 83. Allos Therapeutics Recent Developments
Table 84. Ferring Pharmaceuticals Oncology Injection Drug Basic Information
Table 85. Ferring Pharmaceuticals Oncology Injection Drug Product Overview
Table 86. Ferring Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Ferring Pharmaceuticals Business Overview
Table 88. Ferring Pharmaceuticals Recent Developments
Table 89. Genzyme Oncology Injection Drug Basic Information
Table 90. Genzyme Oncology Injection Drug Product Overview
Table 91. Genzyme Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Genzyme Business Overview
Table 93. Genzyme Recent Developments
Table 94. Eli Lilly Oncology Injection Drug Basic Information
Table 95. Eli Lilly Oncology Injection Drug Product Overview
Table 96. Eli Lilly Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Recent Developments
Table 99. Praecis Pharmaceuticals Oncology Injection Drug Basic Information
Table 100. Praecis Pharmaceuticals Oncology Injection Drug Product Overview
Table 101. Praecis Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Praecis Pharmaceuticals Business Overview
Table 103. Praecis Pharmaceuticals Recent Developments
Table 104. Millennium Pharmaceuticals Oncology Injection Drug Basic Information
Table 105. Millennium Pharmaceuticals Oncology Injection Drug Product Overview
Table 106. Millennium Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Millennium Pharmaceuticals Business Overview
Table 108. Millennium Pharmaceuticals Recent Developments
Table 109. Debiopharm Oncology Injection Drug Basic Information
Table 110. Debiopharm Oncology Injection Drug Product Overview
Table 111. Debiopharm Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Debiopharm Business Overview
Table 113. Debiopharm Recent Developments
Table 114. Alza Oncology Injection Drug Basic Information
Table 115. Alza Oncology Injection Drug Product Overview
Table 116. Alza Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Alza Business Overview
Table 118. Alza Recent Developments
Table 119. CordenPharma Oncology Injection Drug Basic Information
Table 120. CordenPharma Oncology Injection Drug Product Overview
Table 121. CordenPharma Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. CordenPharma Business Overview
Table 123. CordenPharma Recent Developments
Table 124. Pharmascience Oncology Injection Drug Basic Information
Table 125. Pharmascience Oncology Injection Drug Product Overview
Table 126. Pharmascience Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Pharmascience Business Overview
Table 128. Pharmascience Recent Developments
Table 129. Global Oncology Injection Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Oncology Injection Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Oncology Injection Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Oncology Injection Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Oncology Injection Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Oncology Injection Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Oncology Injection Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Oncology Injection Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Oncology Injection Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Oncology Injection Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Oncology Injection Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Oncology Injection Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Oncology Injection Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Oncology Injection Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Oncology Injection Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Oncology Injection Drug Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Oncology Injection Drug Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncology Injection Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Injection Drug Market Size (M USD), 2019-2032
Figure 5. Global Oncology Injection Drug Market Size (M USD) (2019-2032)
Figure 6. Global Oncology Injection Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Injection Drug Market Size by Country (M USD)
Figure 11. Oncology Injection Drug Sales Share by Manufacturers in 2023
Figure 12. Global Oncology Injection Drug Revenue Share by Manufacturers in 2023
Figure 13. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oncology Injection Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oncology Injection Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oncology Injection Drug Market Share by Type
Figure 18. Sales Market Share of Oncology Injection Drug by Type (2019-2024)
Figure 19. Sales Market Share of Oncology Injection Drug by Type in 2023
Figure 20. Market Size Share of Oncology Injection Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Oncology Injection Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oncology Injection Drug Market Share by Application
Figure 24. Global Oncology Injection Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Oncology Injection Drug Sales Market Share by Application in 2023
Figure 26. Global Oncology Injection Drug Market Share by Application (2019-2024)
Figure 27. Global Oncology Injection Drug Market Share by Application in 2023
Figure 28. Global Oncology Injection Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oncology Injection Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Oncology Injection Drug Sales Market Share by Country in 2023
Figure 32. U.S. Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Oncology Injection Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Oncology Injection Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Oncology Injection Drug Sales Market Share by Country in 2023
Figure 37. Germany Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Oncology Injection Drug Sales Market Share by Region in 2023
Figure 44. China Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 50. South America Oncology Injection Drug Sales Market Share by Country in 2023
Figure 51. Brazil Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Oncology Injection Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Oncology Injection Drug Production Market Share by Region (2019-2024)
Figure 62. North America Oncology Injection Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Oncology Injection Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Oncology Injection Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China Oncology Injection Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Oncology Injection Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Oncology Injection Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Oncology Injection Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Oncology Injection Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Oncology Injection Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Oncology Injection Drug Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Oncology Injection Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Injection Drug Market Size (M USD), 2019-2032
Figure 5. Global Oncology Injection Drug Market Size (M USD) (2019-2032)
Figure 6. Global Oncology Injection Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Injection Drug Market Size by Country (M USD)
Figure 11. Oncology Injection Drug Sales Share by Manufacturers in 2023
Figure 12. Global Oncology Injection Drug Revenue Share by Manufacturers in 2023
Figure 13. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oncology Injection Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oncology Injection Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oncology Injection Drug Market Share by Type
Figure 18. Sales Market Share of Oncology Injection Drug by Type (2019-2024)
Figure 19. Sales Market Share of Oncology Injection Drug by Type in 2023
Figure 20. Market Size Share of Oncology Injection Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Oncology Injection Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oncology Injection Drug Market Share by Application
Figure 24. Global Oncology Injection Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Oncology Injection Drug Sales Market Share by Application in 2023
Figure 26. Global Oncology Injection Drug Market Share by Application (2019-2024)
Figure 27. Global Oncology Injection Drug Market Share by Application in 2023
Figure 28. Global Oncology Injection Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oncology Injection Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Oncology Injection Drug Sales Market Share by Country in 2023
Figure 32. U.S. Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Oncology Injection Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Oncology Injection Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Oncology Injection Drug Sales Market Share by Country in 2023
Figure 37. Germany Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Oncology Injection Drug Sales Market Share by Region in 2023
Figure 44. China Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 50. South America Oncology Injection Drug Sales Market Share by Country in 2023
Figure 51. Brazil Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Oncology Injection Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Oncology Injection Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Oncology Injection Drug Production Market Share by Region (2019-2024)
Figure 62. North America Oncology Injection Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Oncology Injection Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Oncology Injection Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China Oncology Injection Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Oncology Injection Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Oncology Injection Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Oncology Injection Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Oncology Injection Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Oncology Injection Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Oncology Injection Drug Market Share Forecast by Application (2025-2032)
